The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C
Abstract
Background aims In hepatitis C there is controversy over the linearity of the rate of progression and the significance of gender, mode of infection and viral factors.Methods 2313 untreated patients with a reliable estimated duration of infection and liver fibrosis were included. Fibrosis progression was calculated using the Kaplan-Meier method and the rate of fibrosis progression using the hazard function. Seven risk factors were assessed: age at biopsy, gender, alcohol consumption, mode of infection, activity grade, hepatitis C virus genotype and RNA level.Results The percentage of patients without cirrhosis was 91% after 20 years of infection (95% CI:90-92%) and 56% after 40 years (95% CI:48-64%). Three independent factors were associated (P < 0.001) with a faster progression rate: age at infection, alcohol consumption of 50 g or more per day, and male gender. The mode of infection, histologic activity, genotype and viral load were not independently associated with fibrosis. Fibrosis progression was mainly dependent on age and the duration of infection and can be divided into four successive periods with very slow, slow, intermediate and rapid progression rates.Conclusion In patients infected with hepatitis C, the majority of fibrosis progression occurred in those aged fifty years or older.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, the beneficial anti-fibrotic effect of ER activators in the hepatic tissue (e.g.17b-estradiol and estradiol) [200][201][202] may also explain sex differences in liver fibrosis and cirrhosis progression.[203][204][205][206]”
From Nuclear receptors in liver fibrosis (2021) · cites this paper as [203]
Citations
Cites
An Algorithm for the Grading of Activity in Chronic Hepatitis C
Bedossa, P., & Poynard, T. (1996) · Hepatology · doi:10.1002/hep.510240201 · Cited by 4,088
Self-citationMcHutchison, J. G., Gordon, S. C., Schiff, E. R., Shiffman, M. L., Lee, W. M., Rustgi, V. K., Goodman, Z. D., Ling, M.-H., Cort, S., & Albrecht, J. K. (1998) · New England Journal of Medicine · doi:10.1056/nejm199811193392101 · Cited by 3,465
Self-citationNatural history of liver fibrosis progression in patients with chronic hepatitis C
Poynard, T., Bedossa, P., & Opolon, P. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07642-8 · Cited by 3,011
Self-citationPoynard, T., Marcellin, P., Lee, S. S., Niederau, C., Minuk, G. S., Ideo, G., Bain, V., Heathcote, J., Zeuzem, S., Trepo, C., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(98)07124-4 · Cited by 2,318
Self-citationBedossa, P. (1994) · Hepatology · doi:10.1002/hep.1840200104 · Cited by 2,003
Clinical Outcomes after Transfusion-Associated Hepatitis C
Tong, M. J., El-Farra, N. S., Reikes, A. R., & Co, R. L. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506013322202 · Cited by 1,198
Alter, M. J. (1997) · Hepatology · doi:10.1002/hep.510260711 · Cited by 1,075
Clinical Outcomes after Hepatitis C Infection from Contaminated Anti-D Immune Globulin
Kenny-Walsh, E. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904223401602 · Cited by 910
Number Cruncher Statistical Systems (NCSS)
McKenzie, J. D., & Hintze, J. L. (1985) · The American Statistician · doi:10.2307/2683719 · Cited by 810
EASL International Consensus Conference on Hepatitis C Paris, 26–28 February 1999
(1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80154-8 · Cited by 700
Research works printed but not linked: 2
- 1997, Hepatitis C: global prevalence, Wkly Epidemiol Rec, 72, 341
- Nagel, 1991, Enumeration of T lymphocytes by monoclonal antibodies in young age and aged humans, J Immunol, 191, 599
Cited by
Sampling Variability of Liver Fibrosis in Chronic Hepatitis C
Bedossa, P., Dargère, D., & Paradis, V. (2003) · Hepatology · doi:10.1016/j.hep.2003.09.022 · Cited by 2,376
Liver fibrosis – from bench to bedside
Friedman, S. L. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00429-4 · Cited by 1,780
“Risk and natural history of fibrosis associated with HCV have been greatly clarified as a result of several large clinical studies incorporating standardized assessments of fibrosis that combine detailed historical and clinical information [8,14].”
BackgroundSingh, S., Allen, A. M., Wang, Z., Prokop, L. J., Murad, M. H., & Loomba, R. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.04.014 · Cited by 1,748
Lai, C. L., Ratziu, V., Yuen, M.-F., & Poynard, T. (2003) · The Lancet · doi:10.1016/s0140-6736(03)15108-2 · Cited by 1,727
Self-citationNatural history of chronic hepatitis C
Seeff, L. B. (2002) · Hepatology · doi:10.1053/jhep.2002.36806 · Cited by 1,424
Metadata
- Authors
- Poynard, T., Ratziu, V., Charlotte, F., Goodman, Z., McHutchison, J., & Albrecht, J.
- Affiliations
- Pitié-Salpêtrière Hospital (FR)
- Armed Forces Institute of Pathology (US)
- Scripps Clinic (US)
- Corresponding author
- Poynard, Thierry
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2001-05
- Volume
- 34
- Issue
- 5
- Pages
- 730-739
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W2001973858
- Cited by
- 749
- References
- 36
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 9 · 2023: 14 · 2022: 16 · 2021: 17 · 2020: 17 · 2019: 30 · 2018: 21 · 2017: 25 · 2016: 25 · 2015: 30 · 2014: 36 · 2013: 25 · 2012: 34
- FWCI
- 27.47
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Journal of Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Association pour la Recherche sur le Cancer
- Topics
- Health Sciences › Medicine › Hepatology › Hepatitis C virus research
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- chronic hepatitis C, liver fibrosis progression, liver cirrhosis, risk factors, age at infection, alcohol consumption, gender differences, infection mode, HCV genotypes, viral load, histologic activity, infection duration
- MeSH terms
- Adult, Aging, Alcohol Drinking, Cross-Sectional Studies, Female, Humans, Liver Cirrhosis, Male, Middle Aged, Risk Factors, Sex Characteristics, Time Factors, Substance Abuse, Intravenous, Proportional Hazards Models, Survival Analysis, Hepatitis C, Chronic, Transfusion Reaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C. https://app.cochat.ai/papers/10.1016/s0168-8278(00)00097-0
- The paper
- Poynard, T., Ratziu, V., Charlotte, F., Goodman, Z., McHutchison, J., & Albrecht, J. (2001). Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C. Journal of Hepatology. https://doi.org/10.1016/s0168-8278(00)00097-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.